Q2 2024
Released Nov 9, 2023, after the close
10-Q filed Nov 9, 2023, 40 days after period end · 0001516513-23-000084
Q2 2024 · 10-Q
Revenue$113.61M$113.61M +11.2% vs Q2 2023+4.7% vs Q1 2024
Net Income$30.60M$30.60M +16.4% vs Q2 2023+7.7% vs Q1 2024
EPS Diluted$0.15$0.15 +25.0% vs Q2 2023+15.4% vs Q1 2024
Gross Profit$100,853,000+13.3%
Operating Income$33,792,000+5.3%
Operating Cash Flowderived$12,898,000−67.4%
Free Cash Flowderived$12,857,000−66.8%
Margins · derived
Gross margin88.8%+1.7 pt vs Q2 2023
Operating margin29.7%−1.7 pt vs Q2 2023
Net margin26.9%+1.2 pt vs Q2 2023
What the release said
The release
Same quarter
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $113.61M | $102.19M | $79.35M | $45.11M |
| Net Income | $30.60M | $26.30M | $36.09M | $10.04M |
| EPS Diluted | $0.15 | $0.12 | $0.17 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Doximity, Inc. · CIK 1516513 · Engraved from SEC EDGAR